It is imperative to align strategies that can prevent ovarian cancer while also strengthening support for patients, caregivers, and health systems that are confronted by it,” the researchers wrote.

Merck Colombia, Janssen-Cilag SA, Novartis, Pfizer SA and AstraZeneca Colombia SA. E Gotuzzo has been a consultant to Pfizer and has received research funds from Johnson & Johnson. M Guzman-Blanco ...

March 3 (UPI) --Colombia President Gustavo Petro is calling ... Mastercard, Pfizer and AstraZeneca, that the world's second-largest economy is open for business amid a looming tariffs threat.

Scientists from the University of Sheffield will warn policymakers that the shrinking glaciers of the Andes threaten the water supply of 90 million people on the South American continent at the ...

AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...

Eneboparatide hits primary endpoint in AstraZeneca’s Phase 3 trial for chronic hypoparathyroidism, showing significant efficacy at 24 weeks. The EU approved AstraZeneca’s Imfinzi for limited ...

AstraZeneca already has cell therapies in its pipeline, and it is now expanding its scope further with a deal to acquire EsoBiotec, a company in early clinical development with therapies made by ...

March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday. The investment will mark the ...

AstraZeneca AZN-1.69%decrease; red down pointing triangle plans to invest $2.5 billion in China over five years to build a research-and-development center and strike deals with local biotechnology ...

AstraZeneca bought Belgian biotech company EsoBiotec in a deal valued at up to $1 billion, to expand its cell-therapy portfolio. The British pharma company said Monday that it will pay $425 ...